Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1251 entries
Sorted by: Best Match Show Resources per page
Cigarette smoking and cardiovascular risk in young women with polycystic ovary syndrome.

International journal of fertility & sterility

Morotti E, Battaglia B, Fabbri R, Paradisi R, Venturoli S, Battaglia C.
PMID: 24520500
Int J Fertil Steril. 2014 Jan;7(4):301-12. Epub 2013 Dec 22.

BACKGROUND: To verify if in lean polycystic ovary syndrome (PCOS) patients, the smok- ing habitude might increase the risk of cardiovascular (CV) disease.MATERIALS AND METHODS: In this prospective observational study, eighty-one women were divided into the following three groups:...

Cite
Morotti E, Battaglia B, Fabbri R, et al. Cigarette smoking and cardiovascular risk in young women with polycystic ovary syndrome. Int J Fertil Steril. 2013;7(4):301-12
Morotti, E., Battaglia, B., Fabbri, R., Paradisi, R., Venturoli, S., & Battaglia, C. (2014). Cigarette smoking and cardiovascular risk in young women with polycystic ovary syndrome. International journal of fertility & sterility, 7(4), 301-12.
Morotti, Elena, et al. "Cigarette smoking and cardiovascular risk in young women with polycystic ovary syndrome." International journal of fertility & sterility vol. 7,4 (2014): 301-12.
Morotti E, Battaglia B, Fabbri R, Paradisi R, Venturoli S, Battaglia C. Cigarette smoking and cardiovascular risk in young women with polycystic ovary syndrome. Int J Fertil Steril. 2014 Jan;7(4):301-12. Epub 2013 Dec 22. PMID: 24520500; PMCID: PMC3901187.
Copy Download .nbib Format: NLM
A crossover study of the combination therapy of metformin and exenatide or biphasic insulin aspart 30 in overweight or obese patients newly diagnosed with type 2 diabetes mellitus.

Experimental and therapeutic medicine

Quan H, Zhang H, Wei W, Fang T, Chen D, Chen K.
PMID: 28912879
Exp Ther Med. 2017 Oct;14(4):3279-3287. doi: 10.3892/etm.2017.4863. Epub 2017 Aug 02.

The aim of the present study was to explore the effects of various combinations of exenatide, metformin (MET) and biphasic insulin aspart 30 (BIA30) on type 2 diabetes mellitus (T2DM). Two hundred overweight or obese patients newly diagnosed with...

Cite
Quan H, Zhang H, Wei W, et al. A crossover study of the combination therapy of metformin and exenatide or biphasic insulin aspart 30 in overweight or obese patients newly diagnosed with type 2 diabetes mellitus. Exp Ther Med. 2017;14(4):3279-3287doi: 10.3892/etm.2017.4863.
Quan, H., Zhang, H., Wei, W., Fang, T., Chen, D., & Chen, K. (2017). A crossover study of the combination therapy of metformin and exenatide or biphasic insulin aspart 30 in overweight or obese patients newly diagnosed with type 2 diabetes mellitus. Experimental and therapeutic medicine, 14(4), 3279-3287. https://doi.org/10.3892/etm.2017.4863
Quan, Huibiao, et al. "A crossover study of the combination therapy of metformin and exenatide or biphasic insulin aspart 30 in overweight or obese patients newly diagnosed with type 2 diabetes mellitus." Experimental and therapeutic medicine vol. 14,4 (2017): 3279-3287. doi: https://doi.org/10.3892/etm.2017.4863
Quan H, Zhang H, Wei W, Fang T, Chen D, Chen K. A crossover study of the combination therapy of metformin and exenatide or biphasic insulin aspart 30 in overweight or obese patients newly diagnosed with type 2 diabetes mellitus. Exp Ther Med. 2017 Oct;14(4):3279-3287. doi: 10.3892/etm.2017.4863. Epub 2017 Aug 02. PMID: 28912879; PMCID: PMC5585756.
Copy Download .nbib Format: NLM
Diabetes mellitus caused by secondary hemochromatosis after multiple blood transfusions in 2 patients with severe aplastic anemia.

Annals of pediatric endocrinology & metabolism

Kim HJ, Kim YM, Kang E, Lee BH, Choi JH, Yoo HW.
PMID: 28443261
Ann Pediatr Endocrinol Metab. 2017 Mar;22(1):60-64. doi: 10.6065/apem.2017.22.1.60. Epub 2017 Mar 31.

Hemochromatosis is an inherited or secondary disorder caused by excessive iron storage leading to multiple organ damage. We describe 2 patients with diabetes mellitus caused by hemochromatosis secondary to multiple blood transfusions due to severe aplastic anemia. Subject 1,...

Cite
Kim HJ, Kim YM, Kang E, et al. Diabetes mellitus caused by secondary hemochromatosis after multiple blood transfusions in 2 patients with severe aplastic anemia. Ann Pediatr Endocrinol Metab. 2017;22(1):60-64doi: 10.6065/apem.2017.22.1.60.
Kim, H. J., Kim, Y. M., Kang, E., Lee, B. H., Choi, J. H., & Yoo, H. W. (2017). Diabetes mellitus caused by secondary hemochromatosis after multiple blood transfusions in 2 patients with severe aplastic anemia. Annals of pediatric endocrinology & metabolism, 22(1), 60-64. https://doi.org/10.6065/apem.2017.22.1.60
Kim, Hyun Jin, et al. "Diabetes mellitus caused by secondary hemochromatosis after multiple blood transfusions in 2 patients with severe aplastic anemia." Annals of pediatric endocrinology & metabolism vol. 22,1 (2017): 60-64. doi: https://doi.org/10.6065/apem.2017.22.1.60
Kim HJ, Kim YM, Kang E, Lee BH, Choi JH, Yoo HW. Diabetes mellitus caused by secondary hemochromatosis after multiple blood transfusions in 2 patients with severe aplastic anemia. Ann Pediatr Endocrinol Metab. 2017 Mar;22(1):60-64. doi: 10.6065/apem.2017.22.1.60. Epub 2017 Mar 31. PMID: 28443261; PMCID: PMC5401825.
Copy Download .nbib Format: NLM
Design, implementation, and evaluation of a pediatric and adolescent type 2 diabetes management program at a tertiary pediatric center.

Journal of multidisciplinary healthcare

Samaan MC, Valencia M, Cheung C, Wilk B, Lau K, Thabane L.
PMID: 25114539
J Multidiscip Healthc. 2014 Jul 31;7:321-31. doi: 10.2147/JMDH.S63842. eCollection 2014.

Global rates of type 2 diabetes in children and adolescents have increased significantly over the past three decades. Type 2 diabetes is a relatively new disease in this age group, and there is a dearth of information about how...

Cite
Samaan MC, Valencia M, Cheung C, et al. Design, implementation, and evaluation of a pediatric and adolescent type 2 diabetes management program at a tertiary pediatric center. J Multidiscip Healthc. 2014;7:321-31doi: 10.2147/JMDH.S63842.
Samaan, M. C., Valencia, M., Cheung, C., Wilk, B., Lau, K., & Thabane, L. (2014). Design, implementation, and evaluation of a pediatric and adolescent type 2 diabetes management program at a tertiary pediatric center. Journal of multidisciplinary healthcare, 7321-31. https://doi.org/10.2147/JMDH.S63842
Samaan, M Constantine, et al. "Design, implementation, and evaluation of a pediatric and adolescent type 2 diabetes management program at a tertiary pediatric center." Journal of multidisciplinary healthcare vol. 7 (2014): 321-31. doi: https://doi.org/10.2147/JMDH.S63842
Samaan MC, Valencia M, Cheung C, Wilk B, Lau K, Thabane L. Design, implementation, and evaluation of a pediatric and adolescent type 2 diabetes management program at a tertiary pediatric center. J Multidiscip Healthc. 2014 Jul 31;7:321-31. doi: 10.2147/JMDH.S63842. eCollection 2014. PMID: 25114539; PMCID: PMC4124128.
Copy Download .nbib Format: NLM
Serum Ceramide Kinase as a Biomarker of Cognitive Functions, and the Effect of Using Two Slimming Dietary Therapies in Obese Middle Aged Females.

Open access Macedonian journal of medical sciences

Moaty MI, Fouad S, El Shebini SM, Kazem YM, Ahmed NH, Mohamed MS, Hussein AM, Arafa AM, Hanna LM, Tapozada ST.
PMID: 27275191
Open Access Maced J Med Sci. 2015 Mar 15;3(1):18-25. doi: 10.3889/oamjms.2015.030. Epub 2015 Feb 26.

AIM: Highlighting the impact of obesity on mental and cognitive functions using serum ceramide kinase enzyme concentration as a biomarker for cognitive evaluation in the middle aged females, and also targeting to control the obesity and simultaneously postponing the...

Cite
Moaty MI, Fouad S, El Shebini SM, et al. Serum Ceramide Kinase as a Biomarker of Cognitive Functions, and the Effect of Using Two Slimming Dietary Therapies in Obese Middle Aged Females. Open Access Maced J Med Sci. 2015;3(1):18-25doi: 10.3889/oamjms.2015.030.
Moaty, M. I., Fouad, S., El Shebini, S. M., Kazem, Y. M., Ahmed, N. H., Mohamed, M. S., Hussein, A. M., Arafa, A. M., Hanna, L. M., & Tapozada, S. T. (2015). Serum Ceramide Kinase as a Biomarker of Cognitive Functions, and the Effect of Using Two Slimming Dietary Therapies in Obese Middle Aged Females. Open access Macedonian journal of medical sciences, 3(1), 18-25. https://doi.org/10.3889/oamjms.2015.030
Moaty, Maha I A, et al. "Serum Ceramide Kinase as a Biomarker of Cognitive Functions, and the Effect of Using Two Slimming Dietary Therapies in Obese Middle Aged Females." Open access Macedonian journal of medical sciences vol. 3,1 (2015): 18-25. doi: https://doi.org/10.3889/oamjms.2015.030
Moaty MI, Fouad S, El Shebini SM, Kazem YM, Ahmed NH, Mohamed MS, Hussein AM, Arafa AM, Hanna LM, Tapozada ST. Serum Ceramide Kinase as a Biomarker of Cognitive Functions, and the Effect of Using Two Slimming Dietary Therapies in Obese Middle Aged Females. Open Access Maced J Med Sci. 2015 Mar 15;3(1):18-25. doi: 10.3889/oamjms.2015.030. Epub 2015 Feb 26. PMID: 27275191; PMCID: PMC4877781.
Copy Download .nbib Format: NLM
Impact of vitamin D receptor gene polymorphisms in pathogenesis of Type-1 diabetes mellitus.

International journal of clinical and experimental medicine

Kamel MM, Fouad SA, Salaheldin O, El-Razek Ael-R, El-Fatah AI.
PMID: 25664062
Int J Clin Exp Med. 2014 Dec 15;7(12):5505-10. eCollection 2014.

BACKGROUND: Type 1 diabetes mellitus (TIDM) results from an immune-mediated destruction of insulin-producing-cells in the pancreatic islets of Langerhans. There are clear differences in immunogenetic predisposition to type1 diabetes among countries. Studies have indicated that vitamin D supplementation in...

Cite
Kamel MM, Fouad SA, Salaheldin O, et al. Impact of vitamin D receptor gene polymorphisms in pathogenesis of Type-1 diabetes mellitus. Int J Clin Exp Med. 2014;7(12):5505-10
Kamel, M. M., Fouad, S. A., Salaheldin, O., El-Razek, A. e. l. -. R., & El-Fatah, A. I. (2014). Impact of vitamin D receptor gene polymorphisms in pathogenesis of Type-1 diabetes mellitus. International journal of clinical and experimental medicine, 7(12), 5505-10.
Kamel, Mahmoud M, et al. "Impact of vitamin D receptor gene polymorphisms in pathogenesis of Type-1 diabetes mellitus." International journal of clinical and experimental medicine vol. 7,12 (2014): 5505-10.
Kamel MM, Fouad SA, Salaheldin O, El-Razek Ael-R, El-Fatah AI. Impact of vitamin D receptor gene polymorphisms in pathogenesis of Type-1 diabetes mellitus. Int J Clin Exp Med. 2014 Dec 15;7(12):5505-10. eCollection 2014. PMID: 25664062; PMCID: PMC4307509.
Copy Download .nbib Format: NLM
The Investigation of Plasma Glucagon-like Peptide-1 Levels in Newly Diagnosed Type 1 Diabetic Children.

The West Indian medical journal

Uslu B, Gurbuz F, Temiz F, Yuksel B, Mungan N, Topaloglu AK.
PMID: 26901603
West Indian Med J. 2015 Sep 03;65(1):141-146. doi: 10.7727/wimj.2014.134.

OBJECTIVE: To reveal the possible role of glucagon-like peptide-1 (GLP-1) in newly diagnosed Type 1 diabetic children.METHODS: Twenty-five newly diagnosed children and 22 healthy children were included in the study.RESULTS: In oral glucose tolerance tests, no correlation was observed...

Cite
Uslu B, Gurbuz F, Temiz F, et al. The Investigation of Plasma Glucagon-like Peptide-1 Levels in Newly Diagnosed Type 1 Diabetic Children. West Indian Med J. 2015;65(1):141-146doi: 10.7727/wimj.2014.134.
Uslu, B., Gurbuz, F., Temiz, F., Yuksel, B., Mungan, N., & Topaloglu, A. K. (2015). The Investigation of Plasma Glucagon-like Peptide-1 Levels in Newly Diagnosed Type 1 Diabetic Children. The West Indian medical journal, 65(1), 141-146. https://doi.org/10.7727/wimj.2014.134
Uslu, B, et al. "The Investigation of Plasma Glucagon-like Peptide-1 Levels in Newly Diagnosed Type 1 Diabetic Children." The West Indian medical journal vol. 65,1 (2015): 141-146. doi: https://doi.org/10.7727/wimj.2014.134
Uslu B, Gurbuz F, Temiz F, Yuksel B, Mungan N, Topaloglu AK. The Investigation of Plasma Glucagon-like Peptide-1 Levels in Newly Diagnosed Type 1 Diabetic Children. West Indian Med J. 2015 Sep 03;65(1):141-146. doi: 10.7727/wimj.2014.134. PMID: 26901603.
Copy Download .nbib Format: NLM
Umbilical Cord Derived Mesenchymal Stem Cells Useful in Insulin Production - Another Opportunity in Cell Therapy.

International journal of stem cells

Sarang S, Viswanathan C.
PMID: 27426087
Int J Stem Cells. 2016 May 30;9(1):60-9. doi: 10.15283/ijsc.2016.9.1.60.

BACKGROUND AND OBJECTIVES: Type 1 Diabetes Mellitus (T1DM) is an autoimmune disorder resulting out of T cell mediated destruction of pancreatic beta cells. Immunomodulatory properties of mesenchymal stem cells may help to regenerate beta cells and/or prevent further destruction...

Cite
Sarang S, Viswanathan C. Umbilical Cord Derived Mesenchymal Stem Cells Useful in Insulin Production - Another Opportunity in Cell Therapy. Int J Stem Cells. 2016;9(1):60-9doi: 10.15283/ijsc.2016.9.1.60.
Sarang, S., & Viswanathan, C. (2016). Umbilical Cord Derived Mesenchymal Stem Cells Useful in Insulin Production - Another Opportunity in Cell Therapy. International journal of stem cells, 9(1), 60-9. https://doi.org/10.15283/ijsc.2016.9.1.60
Sarang, Shabari, and Viswanathan, Chandra. "Umbilical Cord Derived Mesenchymal Stem Cells Useful in Insulin Production - Another Opportunity in Cell Therapy." International journal of stem cells vol. 9,1 (2016): 60-9. doi: https://doi.org/10.15283/ijsc.2016.9.1.60
Sarang S, Viswanathan C. Umbilical Cord Derived Mesenchymal Stem Cells Useful in Insulin Production - Another Opportunity in Cell Therapy. Int J Stem Cells. 2016 May 30;9(1):60-9. doi: 10.15283/ijsc.2016.9.1.60. PMID: 27426087; PMCID: PMC4961105.
Copy Download .nbib Format: NLM
Effects of intensive insulin therapy upon pancreatic β cell function in patients newly diagnosed with type II diabetes.

International journal of clinical and experimental medicine

Wang D, Sun L, Song G, Chen S.
PMID: 25785143
Int J Clin Exp Med. 2015 Jan 15;8(1):1391-5. eCollection 2015.

OBJECTIVE: This study was designed to evaluate the clinical efficacy of intensive insulin therapy for patients newly diagnosed with type 2 diabetes.METHODS: A total of 219 patients newly diagnosed with type 2 diabetes were randomly assigned into insulin group...

Cite
Wang D, Sun L, Song G, et al. Effects of intensive insulin therapy upon pancreatic β cell function in patients newly diagnosed with type II diabetes. Int J Clin Exp Med. 2015;8(1):1391-5
Wang, D., Sun, L., Song, G., & Chen, S. (2015). Effects of intensive insulin therapy upon pancreatic β cell function in patients newly diagnosed with type II diabetes. International journal of clinical and experimental medicine, 8(1), 1391-5.
Wang, Defeng, et al. "Effects of intensive insulin therapy upon pancreatic β cell function in patients newly diagnosed with type II diabetes." International journal of clinical and experimental medicine vol. 8,1 (2015): 1391-5.
Wang D, Sun L, Song G, Chen S. Effects of intensive insulin therapy upon pancreatic β cell function in patients newly diagnosed with type II diabetes. Int J Clin Exp Med. 2015 Jan 15;8(1):1391-5. eCollection 2015. PMID: 25785143; PMCID: PMC4358598.
Copy Download .nbib Format: NLM
TCF7L2 polymorphism is associated with low nitric oxide release, endothelial dysfunction and enhanced inflammatory response after myocardial infarction.

BBA clinical

Cintra R, Moura FA, Carvalho LS, Daher M, Santos SN, Costa AP, Figueiredo VN, Andrade JM, Neves FA, Silva JC, Sposito AC.
PMID: 27213136
BBA Clin. 2016 Apr 02;5:159-65. doi: 10.1016/j.bbacli.2016.03.010. eCollection 2016 Jun.

BACKGOUND: The favorable effects of insulin during myocardial infarction (MI) remain unclear due to the divergence between mechanistic studies and clinical trials of exogenous insulin administration. The rs7903146 polymorphism of the transcription factor 7-like 2 (TCF7L2) gene is associated...

Cite
Cintra R, Moura FA, Carvalho LS, et al. TCF7L2 polymorphism is associated with low nitric oxide release, endothelial dysfunction and enhanced inflammatory response after myocardial infarction. BBA Clin. 2016;5:159-65doi: 10.1016/j.bbacli.2016.03.010.
Cintra, R., Moura, F. A., Carvalho, L. S., Daher, M., Santos, S. N., Costa, A. P., Figueiredo, V. N., Andrade, J. M., Neves, F. A., Silva, J. C., Sposito, A. C. (2016). TCF7L2 polymorphism is associated with low nitric oxide release, endothelial dysfunction and enhanced inflammatory response after myocardial infarction. BBA clinical, 5159-65. https://doi.org/10.1016/j.bbacli.2016.03.010
Cintra, Riobaldo, et al. "TCF7L2 polymorphism is associated with low nitric oxide release, endothelial dysfunction and enhanced inflammatory response after myocardial infarction." BBA clinical vol. 5 (2016): 159-65. doi: https://doi.org/10.1016/j.bbacli.2016.03.010
Cintra R, Moura FA, Carvalho LS, Daher M, Santos SN, Costa AP, Figueiredo VN, Andrade JM, Neves FA, Silva JC, Sposito AC. TCF7L2 polymorphism is associated with low nitric oxide release, endothelial dysfunction and enhanced inflammatory response after myocardial infarction. BBA Clin. 2016 Apr 02;5:159-65. doi: 10.1016/j.bbacli.2016.03.010. eCollection 2016 Jun. PMID: 27213136; PMCID: PMC4865630.
Copy Download .nbib Format: NLM
Recovery from alopecia areata in a patient with autoimmune polyglandular syndrome type 3.

Endocrinology, diabetes & metabolism case reports

Makino S, Uchihashi T, Kataoka Y, Fujiwara M.
PMID: 25759758
Endocrinol Diabetes Metab Case Rep. 2015;2015:140084. doi: 10.1530/EDM-14-0084. Epub 2015 Feb 01.

UNLABELLED: Recovery from alopecia is rare in autoimmune polyglandular syndrome (APS). A 41-year-old male was admitted to our hospital with hyperglycemia. He developed alopecia areata (AA) 5 months before admission and developed thirst, polyuria, and anorexia in 2 weeks....

Cite
Makino S, Uchihashi T, Kataoka Y, et al. Recovery from alopecia areata in a patient with autoimmune polyglandular syndrome type 3. Endocrinol Diabetes Metab Case Rep. 2015;2015:140084doi: 10.1530/EDM-14-0084.
Makino, S., Uchihashi, T., Kataoka, Y., & Fujiwara, M. (2015). Recovery from alopecia areata in a patient with autoimmune polyglandular syndrome type 3. Endocrinology, diabetes & metabolism case reports, 2015140084. https://doi.org/10.1530/EDM-14-0084
Makino, Shinya, et al. "Recovery from alopecia areata in a patient with autoimmune polyglandular syndrome type 3." Endocrinology, diabetes & metabolism case reports vol. 2015 (2015): 140084. doi: https://doi.org/10.1530/EDM-14-0084
Makino S, Uchihashi T, Kataoka Y, Fujiwara M. Recovery from alopecia areata in a patient with autoimmune polyglandular syndrome type 3. Endocrinol Diabetes Metab Case Rep. 2015;2015:140084. doi: 10.1530/EDM-14-0084. Epub 2015 Feb 01. PMID: 25759758; PMCID: PMC4342500.
Copy Download .nbib Format: NLM
Proinsulin C-peptide regulates ribosomal RNA expression.

The Journal of biological chemistry

Lindahl E, Nyman U, Zaman F, Palmberg C, Cascante A, Shafqat J, Takigawa M, Sävendahl L, Jörnvall H, Joseph B.
PMID: 28283590
J Biol Chem. 2017 Mar 10;292(10):4382. doi: 10.1074/jbc.A109.053587.

No abstract available.

Cite
Lindahl E, Nyman U, Zaman F, et al. Proinsulin C-peptide regulates ribosomal RNA expression. J Biol Chem. 2017;292(10):4382doi: 10.1074/jbc.A109.053587.
Lindahl, E., Nyman, U., Zaman, F., Palmberg, C., Cascante, A., Shafqat, J., Takigawa, M., Sävendahl, L., Jörnvall, H., & Joseph, B. (2017). Proinsulin C-peptide regulates ribosomal RNA expression. The Journal of biological chemistry, 292(10), 4382. https://doi.org/10.1074/jbc.A109.053587
Lindahl, Emma, et al. "Proinsulin C-peptide regulates ribosomal RNA expression." The Journal of biological chemistry vol. 292,10 (2017): 4382. doi: https://doi.org/10.1074/jbc.A109.053587
Lindahl E, Nyman U, Zaman F, Palmberg C, Cascante A, Shafqat J, Takigawa M, Sävendahl L, Jörnvall H, Joseph B. Proinsulin C-peptide regulates ribosomal RNA expression. J Biol Chem. 2017 Mar 10;292(10):4382. doi: 10.1074/jbc.A109.053587. PMID: 28283590; PMCID: PMC5354506.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1251 entries